과제정보
The authors wish to acknowledge Sarah Cristofaro and Dr. Ambreen Merchant for their invaluable assistance in study coordination.
참고문헌
- American Cancer Society. Key statistics for esophageal cancer [Internet]. Kennesaw (GA): American Cancer Society; 2021 [cited 2021 Dec 7]. Available from: https://www.cancer.org/cancer/esophagus-cancer/about/key-statistics.html.
- Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin 2013;63:232-248.
- Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-146.
- Hur C, Miller M, Kong CY, et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer 2013;119:1149-1158.
- Dubecz A, Gall I, Solymosi N, et al. Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis. J Thorac Oncol 2012;7:443-447.
- Barnes JA, Willingham FF. Endoscopic management of early esophageal cancer. J Clin Gastroenterol 2015;49:638-646.
- National Institutes of Health. SEER*Stat software (version 8.3.9.2) [Internet]. Bethesda (MD): National Institutes of Health; 2021 [cited 2021 Dec 7]. Available from: https://seer.cancer.gov/seerstat/index.html.
- Greene FL, Balch CM, Fleming ID, et al. AJCC cancer staging handbook: TNM classification of malignant tumors. 6th ed. New York (NY): Springer; 2002.
- Edge S, Byrd DR, Compton CC, et al. AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. New York (NY): Springer; 2010.
- National Institutes of Health. Joinpoint regression program [Internet]. Bethesda (MD): National Institutes of Health [cited 2021 Dec 7]. Available from: https://surveillance.cancer.gov/joinpoint/.
- Murphy CC, Sandler RS, Sanoff HK, et al. Decrease in incidence of colorectal cancer among individuals 50 years or older after recommendations for population-based screening. Clin Gastroenterol Hepatol 2017;15:903-909.e6.
- Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24:4539-4544.
- Banks E, Canfell K. Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible. Breast Cancer Res 2010;12:103.
- He H, Chen N, Hou Y, et al. Trends in the incidence and survival of patients with esophageal cancer: a SEER database analysis. Thorac Cancer 2020;11:1121-1128.
- Haiyu Z, Xiaofeng P, Xiangqiong M, et al. Incidence and survival changes in patients with esophageal adenocarcinoma during 1984-2013. Biomed Res Int 2019;2019:7431850.
- Then EO, Lopez M, Saleem S, et al. Esophageal cancer: an updated surveillance epidemiology and end results database analysis. World J Oncol 2020;11:55-64.
- Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008;57:1200-1206.
- Peters FP, Kara MA, Rosmolen WD, et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 2005;61:506-514.
- Larghi A, Lightdale CJ, Ross AS, et al. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 2007;39:1086-1091.
- Ell C, May A, Pech O, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007;65:3-10.
- May A, Gossner L, Pech O, et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy 2002;34:604-610.
- Seewald S, Akaraviputh T, Seitz U, et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003;57:854-859.
- Manner H, Pech O, Heldmann Y, et al. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 2013;11:630-635.
- Pech O, May A, Manner H, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 2014;146:652-660.e1.
- Gamboa AM, Kim S, Force SD, et al. Treatment allocation in patients with early-stage esophageal adenocarcinoma: prevalence and predictors of lymph node involvement. Cancer 2016;122:2150-2157.
- Ajani JA, D'Amico TA, Almhanna K, et al. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw 2015;13:194-227.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7-30.
- De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes 2013;2013:291546.
- Nieman KM, Romero IL, Van Houten B, et al. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 2013;1831:1533-1541.
- Chang P, Friedenberg F. Obesity and GERD. Gastroenterol Clin North Am 2014;43:161-173.
- Ness-Jensen E, Hveem K, El-Serag H, et al. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2016;14:175-182.e1-e3.
- Schlottmann F, Dreifuss NH, Patti MG. Obesity and esophageal cancer: GERD, Barrett's esophagus, and molecular carcinogenic pathways. Expert Rev Gastroenterol Hepatol 2020;14:425-433.